<DOC>
	<DOCNO>NCT01752556</DOCNO>
	<brief_summary>Primary objective : The efficacy therapeutic decision take respiratory polygraphy ( RP ) polysomnography ( PSG ) use Epworth scale ; Secondary Objective : 1. cost-effectiveness diagnosis therapeutic decision value use Epworth Scale EuroQol 5D . 2. effectiveness therapeutic decision mean : 1 ) quality life test , 2 ) adherence compliance treatment , 3 ) blood pressure MAP , 4 ) biochemistry determination . Design : prospective , randomize , control , open , parallel non-inferiority . 440 patient randomize diagnose follow treatment base RP PSG . The follow-up last 6 month 4 assessment . Statistical analysis : We compare change Epworth scale arm treatment analysis covariance . The premise non-inferiority -2 low limit 95 % IC . Secondary variable analyze use difference independent mean ( non-parametric equivalent ) Chi2 dichotomous variable . Cost-effectiveness : cost generate one another method evaluate effectiveness primary variable use Bayesian technique</brief_summary>
	<brief_title>Cost-effectiveness Home Respiratory Polygraphy</brief_title>
	<detailed_description>Design : Prospective , randomize , control , open , parallel noninferiority . 440 patient randomize diagnose follow treatment base PR PSG generate four group : two treat two untreated CPAP . The latter undergo self-certification home . The monitor 6 month 4 assessment . Statistical analysis : compare change scale Epworth intervention treatment arm use analysis covariance . The premise non-inferiority -1.6 low limit 95 % . Secondary variable analyze independent mean difference ( nonparametric equivalent ) Chi2 dichotomous variable . Cost-effectiveness : cost generate two method measure effectiveness primary endpoint use Bayesian technique</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Inclusion criterion : 1 . Snoring sleep apnea observe partner 2 . Symptoms may secondary apneas/hypopneas concretely , ESS â‰¥10 3 . Age 18 70 4 . Absence clinical suspicion sleep pathology could cause daytime sleepiness Exclusion criterion : 1 . Psychophysical inability complete questionnaires 2. documented structural coronary cardiopathy control medical treatment 3 . CheyennesStokes Syndrome 4 . Patient undergone uvulopalatopharyngoplasty 5 . Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Sleep apnea , Portable monitor , autoCPAP</keyword>
</DOC>